Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
15 Results for "
mouse VEGFA
" in MedChemExpress (MCE) Product Catalog:
Products (15)
15 Results for "mouse VEGFA" in MCE Product Catalog:
9
9 Publications Verification
Cat. No.: HY-P7312
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial G
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P990148
1
1 Cited Publications
Cat. No.: HY-P72775
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial G
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P7421
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial G
Species:
Mouse
Source:
P. pastoris
Cat. No.: HY-P99116
CAS No.: 1607793-29-2
Synonyms: RG7716; RO-6867461
Target:
Cat. No.: HY-RS16537
Target:
Research Areas:
Vegfa Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vegfa gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-163760
CAS No.: 2667585-44-4
ZM-32 is an inhibitor for human antigen R (HuR), that downregulates the expression of VEGF-A and MMP9, and thus inhibits breast cancer tumor angiogenesis. ZM-32 exhibits broad-spectrum anti-proliferative effects in a variety of cancer cell lines, and exhibits antitumor efficacy against MDA-MB-231 in mouse models .
Cat. No.: HY-P992527
Target:
Research Areas:
Cardiovascular Disease Neurological Disease Inflammation/Immunology
Anti-Mouse/Human VEGF-A Antibody (B20-4.1.1) is an anti-VEGF-A antibody . Anti-Mouse/Human VEGF-A Antibody (B20-4.1.1) inhibits IL-17 release. Anti-Mouse/Human VEGF-A Antibody (B20-4.1.1) inhibits spinal cord angiogenesis and spinal cord vascular permeability. Anti-Mouse/Human VEGF-A Antibody (B20-4.1.1) reduces the severity score of experimental autoimmune encephalomyelitis in mice. Anti-Mouse/Human VEGF-A Antibody (B20-4.1.1) alleviates radiation-induced brain necrosis in mice. Anti-Mouse/Human VEGF-A Antibody (B20-4.1.1) can be used for research on experimental autoimmune encephalomyelitis and radiation necrosis .
Cat. No.: HY-P992548
Target:
Research Areas:
JS207 is a humanized IgG4-specific antibody targeting PD-1 and VEGFA . JS207 can block PD-1/PD-L1, PD-1/PD-L2, and VEGFA/VEGFR2 interactions, with IC50 values of 6.37 nM, 4.3 nM, and 3.35 nM, respectively. JS207 can relieve immunosuppression, promote T cell activation and IL-2/IFN-γ release, and induce PD-1 internalization. JS207 can inhibit VEGF-driven angiogenesis and has the property that VEGFA enhances PD-1 internalization. JS207 cross-reacts with cynomolgus monkey PD-1/VEGFA and rat/mouse VEGFA, but does not bind rat/mouse PD-1. JS207 shows antitumor efficacy in mouse colon cancer and melanoma models. JS207 can be used for research related to colon cancer and melanoma .
Cat. No.: HY-P78686
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial Growth Factor; VEGFA Protein; MVCD1
Species:
Mouse
Source:
HEK293
Cat. No.: HY-182700
CAS No.: 717863-53-1
Target:
Research Areas:
NRPa-308 is a potent and orally active Neuropilin-1 (NRP-1) antagonist with an IC50 of 42 μM for inhibiting VEGF-A165 binding to NRP-1. NRPa-308 blocks the specific interaction between VEGF-A165 and NRP-1. NRPa-308 effectively suppresses angiogenesis in vitro and in vivo and reduces the viability of a broad spectrum of human solid and haematological cancer cells. NRPa-308 inhibits tumor growth and prolongs median survival in a human breast cancer xenograft mouse model. NRPa-308 can be used for the research of multiple human malignancies including solid tumors and hematological cancers .
Cat. No.: HY-P992518
Target:
Research Areas:
Cat. No.: HY-P78812
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial G
Species:
Mouse
Source:
E. coli
Cat. No.: HY-P70761
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial G
Species:
Mouse
Source:
P. pastoris
Cat. No.: HY-P78814
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth Factor A; VEGF; VPF; Vascular Permeability Factor; Vascular Endothelial Growth Factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth Factor A121; Vascular Endothelial Growth Factor A165; Vascular Endothelial G
Species:
Mouse
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
